Le Lézard4d
Pfizer's BRAFTOVI® Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial
Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...
Armed robbery in Revesby3d
Pfizer's BRAFTOVI Regimen Boosts Survival in Phase 3 Trial
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
BMJ5d
Comparison of tube shunt implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis
Objective To compare the efficacy and safety of tube shunt implantation with trabeculectomy in the treatment of patients with glaucoma. Methods A systematic literature search was performed for studies ...